vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year. The company reported $9.00 thousand in sales this quarter. This is the same as the same period last year.
Elon Musk Still Wants To Take On Vladimir Putin In Single Combat
As Russia's invasion of Ukraine continues for the fifth month, Tesla Inc (NASDAQ: TSLA) CEO Elon Musk once again touted the possibility of taking on President Vladimir Putin in single combat.
